TFS
AZN icon

Thoroughbred Financial Services’s AstraZeneca AZN Stock Holding History

Thoroughbred Financial Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$796K Sell
4,202
-30
-0.7% -$5.64K 0.04% 341
2026
Q1 		$834K Sell
4,232
-6
-0.1% -$1.16K 0.05% 316
2025
Q4 		$779K Buy
4,238
+158
+4% +$27.7K 0.05% 316
2025
Q3 		$626K Sell
4,080
-201
-5% -$30.4K 0.04% 348
2025
Q2 		$598K Sell
4,281
-8,666
-67% -$1.21M 0.04% 340
2025
Q1 		$1.9M Buy
12,947
+127
+1% +$18.4K 0.12% 178
2024
Q4 		$1.68M Sell
12,820
-1,270
-9% -$178K 0.1% 185
2024
Q3 		$2.19M Sell
14,090
-32
-0.2% -$5.17K 0.14% 139
2024
Q2 		$2.2M Buy
14,122
+8,347
+145% +$1.26M 0.15% 137
2024
Q1 		$782K Sell
5,775
-11,790
-67% -$1.56M 0.08% 236
2023
Q4 		$2.37M Buy
17,565
+1,106
+7% +$144K 0.19% 110
2023
Q3 		$2.23M Buy
16,459
+7,714
+88% +$1.05M 0.22% 96
2023
Q2 		$1.25M Buy
8,745
+620
+8% +$91.2K 0.16% 140
2023
Q1 		$1.13M Buy
8,125
+1,566
+24% +$211K 0.17% 145
2022
Q4 		$889K Buy
+6,559
New +$823K 0.15% 157

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thoroughbred Financial Services's AZN Position: Q2 2026 in Review

Thoroughbred Financial Services reduced its AstraZeneca (AZN) stake by 0.71% in Q2 2026, selling an estimated $5.64K and leaving 4,202 shares worth $796K. The position accounts for 0.04% of the portfolio, ranked #341.

Thoroughbred Financial Services first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.37M in Q4 2023. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Thoroughbred Financial Services held 4,202 shares of AstraZeneca worth $796K as of Q2 2026.
  • Thoroughbred Financial Services sold 30 AstraZeneca shares in Q2 2026, an estimated $5.64K.
  • AstraZeneca made up 0.04% of Thoroughbred Financial Services's portfolio in Q2 2026, its #341 holding.
  • Thoroughbred Financial Services first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
  • Thoroughbred Financial Services's AstraZeneca position peaked at $2.37M in Q4 2023.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Thoroughbred Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.